Skip to main content

Month: April 2023

New Smart Band with Health Monitoring Features to Revolutionize Personal Fitness

SkyQuest’s Wearable Technology market report is an excellent analysis for individuals interested in gaining insight into the valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is written clearly and concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford, USA,, April 11, 2023 (GLOBE NEWSWIRE) — SkyQuest projects that the Wearable Technology market will attain a value of USD 131.60 billion by 2030, with a CAGR of 13.5% over the forecast (2022-2030). The requirement for the safety, security and privacy of the customer’s information is the...

Continue reading

InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares

JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today the pricing of its underwritten public offering of 9,411,765 ordinary shares at an offering price of $4.25 per ordinary share. The offering is expected to close on April 14, 2023, subject to the satisfaction of customary closing conditions. The Company has granted the underwriters a 30-day option to purchase up to 1,411,764 additional ordinary shares at the public offering price, less the underwriting discount. The Company intends to use the net proceeds from the offering to fund the continued development of vilobelimab, general research and development expenses and investments in the Company’s commercial...

Continue reading

Rising Demand for Minimally Invasive Surgeries Drives Endoscope Market Growth

SkyQuest’s Endoscope market report is an excellent analysis for individuals interested in gaining insight into the valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is written clearly and concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford USA, April 11, 2023 (GLOBE NEWSWIRE) — SkyQuest projects that the Endoscope market will attain a value of USD 13.6 billion by 2030, with a CAGR of 9.4% over the forecast (2022-2030). Some of the key factors projected to propel market expansion over the forecast years are the rise in the frequency of...

Continue reading

HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2023 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that new and updated clinical and non-clinical data related to five HUTCHMED investigational drug candidates will be presented during the American Association for Cancer Research Annual Meeting 2023 (AACR 2023), which will take place from April 14 to 19, 2023 in Orlando, Florida. SavolitinibTitle:   A multicenter Phase II study of savolitinib in patients with MET-amplified gastroesophageal junction adenocarcinomas or gastric cancerLead Author:   Lin Shen, MD, Peking University Cancer Hospital & InstituteType:   Poster presentationSession Number:   PO.CT02.01 – Phase II Clinical Trials 1Abstract Link:   https://www.abstractsonline.com/pp8/#!/10828/presentation/10376     Title:   Baseline...

Continue reading

The Keg Royalties Income Fund announces April 2023 cash distribution

VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced that its April 2023 distribution of $0.0946 per unit has been declared and is payable to unitholders of record as at April 21, 2023. The April 2023 distribution will be paid on April 28, 2023. The Fund is a limited purpose, open-ended trust established under the laws of the Province of Ontario that, through The Keg Rights Limited Partnership, a subsidiary of the Fund, owns certain trademarks and other related intellectual property used by Keg Restaurants Ltd. (“KRL”). In exchange for use of those trademarks, KRL pays the Fund a royalty of 4% of gross sales of Keg restaurants included in the royalty pool. With approximately 10,000 employees, over 100 restaurants and annual system sales approaching...

Continue reading

Update: LiveOne Prepares for PodcastOne Listing on a National Exchange Anticipated to Open at $8 to $12 Per Share – Expected Symbol PODC

– PodcastOne Repays $1 Million of Its Debt Convertible at $3 and Expects to Repay an Additional $1 Million to $2 Million – Extends Record Date to April 20, 2023 – Increases Dividend of PodcastOne Shares to LiveOne’s Shareholders of Record to Between 12% and 16% – LiveOne’s Buyback Exceeds 2,245,000 Shares to Date Leaving Capacity to Repurchase an Additional $1,600,000 Worth of Shares LOS ANGELES, CA,, April 11, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, provided today an update on its planned spin-out of PodcastOne as a separate public company and other updates as set forth above.  About LiveOne, Inc.Headquartered in Los Angeles, California, LiveOne, Inc. (NASDAQ: LVO) (the “Company”)...

Continue reading

Fr8Tech (FRGT) Regains Compliance with Nasdaq Listing Rule

HOUSTON, April 11, 2023 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT, Fr8Tech or Company), a technology company developing solutions to optimize and automate the supply chain process and providing its Fr8App platform for B2B cross-border shipping in the USMCA region, Fr8now for LTL shipping services in Mexico and Fr8Fleet for dedicated capacity to enterprise companies in Mexico, previously announced that it received written notification on October 26, 2022, from The Nasdaq Stock Market LLC that it no longer complied with the minimum bid price requirement for continued listing on the Nasdaq Capital Market pursuant to the Nasdaq Listing Rule 5550(a)(2). The closing bid price for the Company’s ordinary shares had fallen below $1.00 per share for 30 consecutive business days and accordingly, the Company no longer...

Continue reading

HF Foods Adopts Limited Duration Stockholder Rights Plan

LAS VEGAS, April 11, 2023 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG), a leading food distributor to Asian restaurants across the United States (“HF Foods” or the “Company”), today announced that the Board of Directors (the “Board”) has approved the adoption of a limited duration stockholder rights plan (the “Rights Plan”) and declared a dividend distribution of one right (“Right”) for each outstanding share of the Company’s common stock to stockholders of record as of the close of business on April 24, 2023. The Board adopted the Rights Plan out of concern that parties may be engaging in undisclosed stock accumulation and group formation activities to gain control of HF Foods, depriving stockholders of both the opportunity to realize the full value of their investment in the Company and the opportunity to determine the...

Continue reading

Aligos Therapeutics to Present Data from Chronic Hepatitis B and Hepatocellular Carcinoma Programs at the European Association for the Study of the Liver (EASL) Congress 2023

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that the company will present seven posters collectively highlighting data out of five of its liver disease programs at the European Association for the Study of the Liver (EASL) Congress 2023, taking place in Vienna, Austria, June 21 – 24, 2023. The presentations will be available on the Scientific Presentations and Conferences page on Aligos’ corporate website following the meeting. “We are pleased to present seven abstracts at this year’s EASL meeting,” said Lawrence Blatt, Ph.D., MBA, Chairman & CEO of Aligos Therapeutics. “We believe these programs demonstrate...

Continue reading

Banco Itaú Chile Files Material Event Notice announcing the Placement of Bonds in the local market

SANTIAGO, Chile, April 11, 2023 (GLOBE NEWSWIRE) — BANCO ITAÚ CHILE (NYSE: ITCB; SSE: ITAUCORP) announced that it filed today a Material Event Notice with the Chilean Commission for the Financial Market reporting that on this date, the settlement and placement of Banco Itaú Chile dematerialized and bearer bonds in the local market, charged to the Line of Bonds registered in the Securities Registry of the CMF, under No. 3/2022. The specific conditions of placement were as follows:Series “DP” Bonds, Code BITADP0222, for a total amount of UF 1,500,000 (Unidades de Fomento), collecting the sum of CLP $ 51,198,697,758.- with a maturity date of August 9, 2034, at an average placement rate of 2.68%.The full Material Event Notice is available on the company’s investor relations website at ir.itau.cl. Investor Relations – Itaú Chile +56...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.